NCT02534506 Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors Status COMPLETED Phase PHASE1
NCT02533960 Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime Status COMPLETED Phase N/A
NCT02532673 Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir Status COMPLETED Phase N/A
NCT02531269 Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period Status COMPLETED Phase N/A
NCT02526017 Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Status COMPLETED Phase PHASE1
NCT02524977 Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation Status COMPLETED Phase NA
NCT02516527 A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02514304 Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding Status COMPLETED Phase N/A
NCT02504268 Effects of Abatacept in Patients With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT02499367 Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients Status UNKNOWN Phase PHASE2
NCT02497508 Nivolumab in Patients With Recurrent Malignant Mesothelioma Status COMPLETED Phase PHASE2
NCT02496078 A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection Status COMPLETED Phase PHASE3
NCT02492828 Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden Status COMPLETED Phase N/A
NCT02492815 PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma Status COMPLETED Phase N/A
NCT02488759 An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02488421 Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2 Status COMPLETED Phase N/A
NCT02481830 Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02481297 Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients Status COMPLETED Phase PHASE2